Zusammenfassung
Die Kindheit ist eine Zeit des Wachstums. Dieses ist ist ein komplexer, multifaktoriell gesteuerter Prozess. Man unterscheidet primäre und sekundäre Faktoren, die das Längenwachstum beim Kind beeinflussen. Hormone gehören zu den sekundären Faktoren und sind in unterschiedlicher Weise an der Entwicklung des Organismus beim prä- und postnatalen Wachstum beteiligt. Eine zentrale Rolle kommt IGF-I zu, welches sowohl prä- als auch postnatal für eine normale Entwicklung unerlässlich ist. Nach neuerer Erkenntnis scheint lokal in vielen Geweben gebildetes IGF-I für die Wachstumsprozesse wichtiger als das von der Leber gebildete und im Blut zirkulierende IGF-I. Wachstumshormon ist für die Bildung von IGF-I nach der Geburt wichtig, spielt aber fetal für dessen Regulation keine wesentliche Rolle. Auch Insulin ist als Wachstumsfaktor fetal und postnatal wichtig. Die Schilddrüsenhormone tragen postnatal ganz wesentlich zum Längenwachstum bei, sind fetal dazu jedoch nicht erforderlich. Die Sexualhormone sind am pubertären Wachstumsspurt beteiligt, bei beiden Geschlechtern ist Östradiol für den Schluss der Epiphysenfugen und die Beendigung des Wachstums verantwortlich.
Abstract
Childhood is a time of growth. Growth is a complex, multifactorial process. A distinction is made between primary and secondary factors influencing linear growth. Hormones are secondary factors and affect prenatal and postnatal growth and development in different ways. IGF-I is a central factor, being essential for normal fetal and postnatal growth. Recent data suggest that the IGF-I produced locally in many tissues, which acts in a paracrine and autocrine fashion, is more important for growth than the systemic IGF-I produced by the liver. Postnatally, the production of IGF-I is dependent on growth hormone (GH), but during fetal life GH is not required for regulation of IGF-I until shortly before term. Insulin is recognized as another important fetal and postnatal growth factor. Thyroid hormones make a major contribution to postnatal linear growth, but are not required for fetal growth. Sex hormones initiate puberty and the pubertal growth spurt. In both males and females, closure of the epiphyseal plates and termination of growth is ultimately mediated by estradiol.
Literatur
Abuzzahab MJ, Schneider A, Goddard A et al. (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211–2222
Accili D, Drago J, Lee EJ et al. (1996) Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106–109
Albertsson-Wikland K, Boguszewski M, Karlberg J (1998) Children born small for gestational age: postnatal growth and hormonal status. Horm Res 49:7–13
Butler AA, LeRoith D (2001) Minireview: tissue-specific versus generalized gene targeting of the IGF1 and IGF1R genes and their roles in insulin-like growth factor physiology. J Clin Endocrinol Metab 142:1685–1688
DeChiara TM, Efstratiadis A, Robertson EJ (1990) A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature 345:78–80
Domenė HM, Bengolea SV, Martinez AS et al. (2004) Deficiency of the circulating insulin-like growth factor system associated with inactivation of the acid-labile subunit. N Engl J Med 350:570–577
Heyerdahl S, Ilicki A, Karlberg J et al. (1997) Linear growth in early-treated children with congenital hypothyroidism. Acta Paediatr Scand 86:479–483
Hill DJ, Millner RDG (1985) Insulin as a growth factor. Pediatr Res 19:879–886
Isaksson OG, Jansson JO, Gause IA (1982) Growth hormone stimulates longitudinal bone growth directly. Science 216:1237–1239
Kant SG, Wit JM, Breuning MH (2003) Genetic analysis of short stature. Horm Res 60:157–165
LeRoith D, Bondy C, Yakar S et al. (2001) The somatomedin hypothesis: 2001. Endocr Rev 22:53–74
Liu JP, Baker J, Perkins AS et al. (1993) Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:73–82
Mandell F, Berenberg W (1974) The Mauriac syndrome. Am J Dis Child 127:900–902
Morishima A, Grumbach MM, Simpson ER et al. (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689–3698
Noelle V, Schwarz HP, Kiess W et al. (2001) Moderne Behandlungskonzepte für Kinder und Jugendliche mit Diabetes mellitus Typ 1. Monatsschr Kinderheilkd 149:650–659
Reiter EO, Rosenfeld RG (2003) Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S et al. (eds) Williams textbook of endocrinology. Saunders, London, pp 1003–1114
Rivkees SA, Bode HH, Crawford JD (1988) Long-term growth in juvenile acquired hypothyroidism. N Engl J Med 318:599–602
Salmon WD, Daughaday WH (1957) A hormonally-controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med 49:825–826
Schlechter NL, Russell SM, Spencer EM et al. (1986) Evidence suggesting that the direct growth-promoting effect of growth hormone on cartilage in vivo is mediated by local production of somatomedin. Proc Natl Acad Sci USA 83:7932–7934
Schmidt H, Bechtold S, Schwarz HP (2000) Prader-Willi-Labhardt syndrome: auxological response to a conventional dose of growth hormone in patients with classical growth hormone deficiency. Eur J Med Res 5:307–310
Sjogren K, Liu JL, Blad K et al. (1999) Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci USA 96:7088–7092
Smith EP, Boyd J, Frank GR et al. (1994) Estrogen resistance caused by a mutation in the estrogen receptor-gene of a man. N Engl J Med 331:1056–1061
Woods KA, Camacho-Hubner C, Savage MO et al. (1996) Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 335:1342–1349
Yakar S, Liu JL, Stannard B et al. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 96:7324–7329
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schwarz, H.P., Bechtold, S. & Schmidt, H. Hormonelle Kontrolle des Wachstums . Monatsschr Kinderheilkd 152, 501–508 (2004). https://doi.org/10.1007/s00112-004-0947-7
Issue Date:
DOI: https://doi.org/10.1007/s00112-004-0947-7